Suchergebnisse - "Spiekermann, Karsten"

PubPharm (46)

1

ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia : a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Metzeler, K. | Dufour, A. | Benthaus, T. | +12

2

NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS)

enthalten in: Blood | 2009

von Schneider, F. | Hoster, E. | Unterhalt, M. | +17

3

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia : a pilot study of the AMLCG

enthalten in: Blood | 2009

von Braess, J. | Spiekermann, K. | Staib, P. | +22

4

CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2009

von Reindl, C. | Quentmeier, H. | Petropoulos, K. | +11

5

Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR : clonal evolution is a limiting factor

enthalten in: British journal of haematology | 2009

von Papadaki, C. | Dufour, A. | Seibl, M. | +6

6

Age-related risk profile and chemotherapy dose response in acute myeloid leukemia : a study by the German Acute Myeloid Leukemia Cooperative Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2009

von Büchner, T. | Berdel, W. | Haferlach, C. | +17

7

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2009

von Büchner, T. | Berdel, W. | Haferlach, C. | +16

8

Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor

enthalten in: British journal of haematology | 2009

von Papadaki, C. | Dufour, A. | Seibl, M. | +6

9

CBL Exon 8-9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor-11q Deletion Acute Myeloid Leukemia-Myelodysplastic Syndrome Subtypes

enthalten in: Clinical cancer research | 2009

von Reindl, C. | Quentmeier, H. | Petropoulos, K. | +11

10

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG

enthalten in: Blood | 2009

von Braess, J. | Spiekermann, K. | Staib, P. | +16

1
2
3
4
5
Nächster »
[5]